Fang, X.; Border, J.J.; Zhang, H.; Challagundla, L.; Kaur, J.; Hwang, S.H.; Hammock, B.D.; Fan, F.; Roman, R.J.
A Soluble Epoxide Hydrolase Inhibitor Improves Cerebrovascular Dysfunction, Neuroinflammation, Amyloid Burden, and Cognitive Impairments in the hAPP/PS1 TgF344-AD Rat Model of Alzheimer’s Disease. Int. J. Mol. Sci. 2025, 26, 2433.
https://doi.org/10.3390/ijms26062433
AMA Style
Fang X, Border JJ, Zhang H, Challagundla L, Kaur J, Hwang SH, Hammock BD, Fan F, Roman RJ.
A Soluble Epoxide Hydrolase Inhibitor Improves Cerebrovascular Dysfunction, Neuroinflammation, Amyloid Burden, and Cognitive Impairments in the hAPP/PS1 TgF344-AD Rat Model of Alzheimer’s Disease. International Journal of Molecular Sciences. 2025; 26(6):2433.
https://doi.org/10.3390/ijms26062433
Chicago/Turabian Style
Fang, Xing, Jane J. Border, Huawei Zhang, Lavanya Challagundla, Jasleen Kaur, Sung Hee Hwang, Bruce D. Hammock, Fan Fan, and Richard J. Roman.
2025. "A Soluble Epoxide Hydrolase Inhibitor Improves Cerebrovascular Dysfunction, Neuroinflammation, Amyloid Burden, and Cognitive Impairments in the hAPP/PS1 TgF344-AD Rat Model of Alzheimer’s Disease" International Journal of Molecular Sciences 26, no. 6: 2433.
https://doi.org/10.3390/ijms26062433
APA Style
Fang, X., Border, J. J., Zhang, H., Challagundla, L., Kaur, J., Hwang, S. H., Hammock, B. D., Fan, F., & Roman, R. J.
(2025). A Soluble Epoxide Hydrolase Inhibitor Improves Cerebrovascular Dysfunction, Neuroinflammation, Amyloid Burden, and Cognitive Impairments in the hAPP/PS1 TgF344-AD Rat Model of Alzheimer’s Disease. International Journal of Molecular Sciences, 26(6), 2433.
https://doi.org/10.3390/ijms26062433